EUVIMEDEUVIMED entdecken
Crossref

Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder

Munikumar Chembeti

Medical – Clinical – Research · 31.07.2026 · 2 (7)

DOI: 10.52106/3069-9088.1027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical – Clinical – Research, online erschienen am 31.07.2026. Verfasst von Munikumar Chembeti.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 17-year-old male with a history of asthma and dyspraxia presented with recurrent tonic-clonic episodes rapidly progressing to refractory status epilepticus (RSE). Standard management was of limited effectiveness. Analysis of laboratory data suggested mitochondrial disease, and genetic sequencing confirmed a homozygous pathogenic variant in the polymerase gamma (POLG) gene (c.1399G>A; p.Ala467Thr). A combination of non-traditional agents ultimately provided seizure control, as conventional antiepileptic drugs like sodium valproate were strictly contraindicated. Tracheostomy became necessary due to profound muscle weakness. Furthermore, the patient’s age, sitting right on the threshold of adulthood, placed him in a challenging category for practical matters of consent and clinical categorization.

Zitieren

APA

Chembeti, M. (2026). Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder. Medical – Clinical – Research, 2(7). https://doi.org/10.52106/3069-9088.1027

Vancouver

Chembeti M. Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder. Medical – Clinical – Research. 2026;2(7). doi:10.52106/3069-9088.1027

BibTeX
@article{Chembeti2026,
  author = {Chembeti, Munikumar},
  title = {Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder},
  journal = {Medical – Clinical – Research},
  year = {2026},
  volume = {2},
  number = {7},
  doi = {10.52106/3069-9088.1027}
}
Kostenlos starten →